In Vitro Activity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci

Enterococci that are nonsusceptible (NS; MIC > 4 μg/ml) to daptomycin are an emerging clinical concern. The synergistic combination of daptomycin plus beta-lactams has been shown to be effective against vancomycin-resistant Enterococcus (VRE) species in vitro. This study systematically evaluated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Hindler, Janet A., Wong-Beringer, Annie, Charlton, Carmen L., Miller, Shelley A., Kelesidis, Theodoros, Carvalho, Marissa, Sakoulas, George, Nonejuie, Poochit, Pogliano, Joseph, Nizet, Victor, Humphries, Romney
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2015
Schlagworte:
Susceptibility
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468720/
https://ncbi.nlm.nih.gov/pubmed/25963982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05077-14
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge